Market Overview

UPDATE: Goldman Sachs Upgrades Hill-Rom Holdings to Buy Hospita Bed Market Rebound

Related HRC
Earnings Scheduled For January 27, 2017
Benzinga's Top Upgrades, Downgrades For January 24, 2017

Goldman Sachs raised its rating on Hill-Rom Holdings (NYSE: HRC) from Neutral to Buy and increased its price target from $30 to $39.

Goldman Sachs commented, "Our Buy rating is based on the following: (1) a stabilization and potential improvement in the company's core bed business, notably in the US, which should help drive a positive inflection point on the top line in the near to intermediate term; (2) International expansion helping to support longer term results; and (3) an improved outlook on the company's M&A strategy."

Hill-Rom Holdings closed at $28.07 on Monday.

Latest Ratings for HRC

Feb 2017BarclaysInitiates Coverage OnOverweight
Jan 2017Stifel NicolausInitiates Coverage OnBuy
Jun 2016Morgan StanleyUpgradesEqual-WeightOverweight

View More Analyst Ratings for HRC
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Upgrades Intraday Update Analyst Ratings


Related Articles (HRC)

View Comments and Join the Discussion!